SG11201402993XA - Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof - Google Patents

Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof

Info

Publication number: SG11201402993XA
Authority: SG; Singapore
Prior art keywords: lactic acid; metabolism; acid bacterium; treatment product; containing lactic
Prior art date: 2011-12-07

Application number

SG11201402993XA

Inventor

Futoshi Nakamura

Nobuhisa Ashida

Yu Ishida

Shigeru Fujiwara

Original Assignee

Calpis Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-12-07

Filing date

2012-12-06

Publication date

2014-09-26

2012-12-06 Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd

2014-09-26 Publication of SG11201402993XA publication Critical patent/SG11201402993XA/en

Links

JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title 2
241000894006 Bacteria Species 0.000 title 1
235000014655 lactic acid Nutrition 0.000 title 1
239000004310 lactic acid Substances 0.000 title 1
230000037356 lipid metabolism Effects 0.000 title 1
230000004060 metabolic process Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/115—Amylovorus
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/145—Gasseri
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Mycology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Polymers & Plastics (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
General Engineering & Computer Science (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)

SG11201402993XA 2011-12-07 2012-12-06 Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof SG11201402993XA (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2011268313		2011-12-07
JP2012067187		2012-03-23
PCT/JP2012/081597 WO2013084971A1 (en)	2011-12-07	2012-12-06	Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof

Publications (1)

Publication Number	Publication Date
SG11201402993XA true SG11201402993XA (en)	2014-09-26

Family

ID=48574329

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG11201402993XA SG11201402993XA (en)	2011-12-07	2012-12-06	Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
SG10201609078TA SG10201609078TA (en)	2011-12-07	2012-12-06	Lipid Metabolism And/Or Sugar Metabolism Improver Containing Lactic Acid Bacterium Or Treatment Product Thereof

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG10201609078TA SG10201609078TA (en)	2011-12-07	2012-12-06	Lipid Metabolism And/Or Sugar Metabolism Improver Containing Lactic Acid Bacterium Or Treatment Product Thereof

Country Status (11)

Country	Link
US (2)	US20140322172A1 (en)
EP (1)	EP2789340A4 (en)
JP (3)	JP5690416B2 (en)
KR (2)	KR20150000867A (en)
CN (1)	CN104010648A (en)
AU (1)	AU2012349340B2 (en)
CA (1)	CA2861533C (en)
MY (1)	MY172363A (en)
PH (1)	PH12014501254A1 (en)
SG (2)	SG11201402993XA (en)
WO (1)	WO2013084971A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013084971A1 (en) *	2011-12-07	2013-06-13	カルピス株式会社	Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
WO2013130773A2 (en)	2012-02-29	2013-09-06	Ethicon Endo-Surgery, Inc.	Compositions of microbiota and methods related thereto
WO2014077365A1 (en) *	2012-11-16	2014-05-22	カルピス株式会社	Stress-induced bowel disorder-relieving agent comprising specific lactobacillus gasseri strain or treatment product thereof
EP3016511B1 (en) *	2013-07-02	2019-10-09	Austrianova Singapore Pte Ltd.	A method of freeze-drying encapsulated cells, compositions suitable for freezing of encapsulated cells and use of such compositions
JP6557605B2 (en) *	2013-11-07	2019-08-07	サントリーホールディングス株式会社	Intestinal barrier function enhancer containing lactic acid bacteria
EP3165599A4 (en) *	2014-05-29	2017-12-27	Nitto Pharmaceutical Industries, Ltd.	Novel lactic acid bacterium and composition including said lactic acid bacterium
EP3881680A1 (en)	2014-10-31	2021-09-22	Pendulum Therapeutics, Inc.	Methods and compositions relating to microbial treatment
JP5703513B1 (en) *	2014-11-05	2015-04-22	沖縄ハム総合食品株式会社	Novel lactic acid strain and fermentation composition and fermentation extract thereof
BR112018001187B1 (en)	2015-07-20	2022-02-15	Quorum Innovations, Llc	BACTERIAL COMPOSITION, ITS USES, METHOD TO IMPROVE SKIN CONDITION AND METHOD FOR DISINFECTION OF A SURFACE
JP2017108679A (en) *	2015-12-16	2017-06-22	株式会社オヴァールリエゾン	chocolate confectionery
JP6961339B2 (en) *	2015-12-18	2021-11-05	アサヒ飲料株式会社	Beverage containing microbial cells
EP3479837B1 (en) *	2016-06-30	2023-09-06	Asahi Group Holdings, Ltd.	Renal anemia ameliorating composition
JP6923883B2 (en) *	2016-06-30	2021-08-25	アサヒグループホールディングス株式会社	Compositions for use in improving nutritional status
EP3675882A4 (en)	2017-08-30	2021-07-28	Pendulum Therapeutics, Inc.	Methods and compositions for treatment of microbiome-associated disorders
KR101935762B1 (en) *	2018-08-25	2019-01-04	김민재	Composition for supporting administration to animal and methods for preparing the same
JP6480630B1 (en) *	2018-09-26	2019-03-13	アサヒグループホールディングス株式会社	Fat accumulation inhibitor and blood lipid improving agent
CN109666615B (en) *	2019-02-20	2021-03-19	无限极（中国）有限公司	Probiotic composition and application thereof
IL288799B1 (en) *	2019-06-11	2024-04-01	Advance Pharmaceutical Inc	Super-oxide dismutase soluble fiber compositions
KR102229090B1 (en) *	2019-07-26	2021-03-19	(주)성운파마코피아	A composition for preventing, improving or treating ischemic brain disease
JP7364390B2 (en) *	2019-08-19	2023-10-18	株式会社明治	Composition for improving sugar metabolism
KR102271528B1 (en) *	2020-01-03	2021-07-02	경희대학교 산학협력단	Composition for preventing and treating of obesity or diabetes comprising stevia powder coated with lactic acid cell lysate
CN111235058B (en) *	2020-02-20	2022-11-15	江苏微康生物科技有限公司	Bifidobacterium breve with effects of repairing ultraviolet injury, relieving inflammation and preventing skin photoaging, and its preparation method and application
KR102128098B1 (en) *	2020-03-23	2020-06-30	주식회사 종근당바이오	Lactobacillus delbrueckii subsp. lactis CDKDB001 strain, and Composition for preventing, alleviating, or treating NAFLD comprising the same
KR102257130B1 (en) *	2020-06-16	2021-05-28	주식회사 엠디헬스케어	Composition for Prevention or Treatment of Neurological or Mental Disorders Comprising Extracellular Vesicles Derived from Lactobacillus paracasei

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS61109729A (en)	1984-11-05	1986-05-28	Advance Res & Dev Co Ltd	Cholesterol lowering agent
JPS61271223A (en) *	1985-05-24	1986-12-01	Biofuerumin Seiyaku Kk	Improver for blood lipid
JP3359827B2 (en) *	1996-10-29	2002-12-24	株式会社ヤクルト本社	Lipid metabolism improver and food containing it
EP0856259B1 (en)	1996-12-23	1998-08-12	SITIA-YOMO S.p.A.	Composition for feed use comprising lyophilized live lactic bacteria
JP3777296B2 (en)	2000-09-04	2006-05-24	明治製菓株式会社	Method for reducing or removing cholesterol by lactic acid bacteria
JP2003306436A (en)	2002-02-15	2003-10-28	Snow Brand Milk Prod Co Ltd	Inhibitor of increased serum cholesterol level
AU2003256419A1 (en) *	2002-08-21	2004-03-11	Merck & Co., Inc.	Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin ii type i receptor antagonist
JP2007504285A (en) *	2003-01-17	2007-03-01	メルク　エンド　カムパニー　インコーポレーテッド	N-cyclohexylaminocarbonylbenzenesulfonamide derivative
JP5025930B2 (en) *	2005-09-13	2012-09-12	株式会社桃屋	Body fat percentage reducing agent containing Lactobacillus plantarum cells as active ingredients
JP4336992B2 (en)	2006-01-20	2009-09-30	日清食品ホールディングス株式会社	Novel lactic acid bacteria with blood cholesterol-reducing action
JP2007284260A (en) *	2006-04-12	2007-11-01	ＳｕｍｃｏＴｅｃｈｘｉｖ株式会社	Method for manufacturing silicon single crystal
JP2007284360A (en)	2006-04-13	2007-11-01	Mitsukan Group Honsha:Kk	Composition for activating ppar-dependent gene transcription, originated from lactobacillus
JP5314421B2 (en) *	2006-05-31	2013-10-16	株式会社明治	Culture method of lactic acid bacteria with high immunomodulating activity
JP5247012B2 (en)	2006-07-25	2013-07-24	雪印メグミルク株式会社	Fatty liver suppressant
ITMI20062363A1 (en) *	2006-12-06	2008-06-07	Aat Advanced Analytical Technology	PROBIOTIC LATTOBACILLI STRIPS THAT PERSISTLE IN THE INTESTINE AND MODULATE THE MUCOSA RECEPTORS
JP2008214253A (en) *	2007-03-02	2008-09-18	Snow Brand Milk Prod Co Ltd	Visceral fat reduction agent
EP2506863A4 (en) *	2009-12-04	2013-07-17	Technologie Biolactis Inc	Method of regulating ppar, obesity related pathways and their associated metabolic impact
WO2011155518A1 (en) *	2010-06-08	2011-12-15	カルピス株式会社	Lipid metabolism-improving agent
JP2012067187A (en)	2010-09-24	2012-04-05	Riso Kagaku Corp	Nonaqueous inkjet ink
WO2013084971A1 (en) *	2011-12-07	2013-06-13	カルピス株式会社	Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
WO2014077365A1 (en)	2012-11-16	2014-05-22	カルピス株式会社	Stress-induced bowel disorder-relieving agent comprising specific lactobacillus gasseri strain or treatment product thereof
JP2014165231A (en) *	2013-02-22	2014-09-08	Fujitsu Ltd	Electronic component unit and fixing structure

2012
- 2012-12-06 WO PCT/JP2012/081597 patent/WO2013084971A1/en active Application Filing
- 2012-12-06 MY MYPI2014001658A patent/MY172363A/en unknown
- 2012-12-06 KR KR1020147018122A patent/KR20150000867A/en active Search and Examination
- 2012-12-06 JP JP2013548286A patent/JP5690416B2/en active Active
- 2012-12-06 SG SG11201402993XA patent/SG11201402993XA/en unknown
- 2012-12-06 AU AU2012349340A patent/AU2012349340B2/en active Active
- 2012-12-06 EP EP12855562.0A patent/EP2789340A4/en not_active Withdrawn
- 2012-12-06 US US14/363,150 patent/US20140322172A1/en not_active Abandoned
- 2012-12-06 KR KR1020177024273A patent/KR101809695B1/en active IP Right Grant
- 2012-12-06 CA CA2861533A patent/CA2861533C/en active Active
- 2012-12-06 SG SG10201609078TA patent/SG10201609078TA/en unknown
- 2012-12-06 CN CN201280059978.4A patent/CN104010648A/en active Pending
2014
- 2014-06-04 PH PH12014501254A patent/PH12014501254A1/en unknown
- 2014-08-14 JP JP2014165231A patent/JP5690435B2/en active Active
2015
- 2015-01-30 JP JP2015017278A patent/JP6165185B2/en active Active
2017
- 2017-01-18 US US15/408,722 patent/US10245291B2/en active Active

Also Published As

Publication number	Publication date
PH12014501254A1 (en)	2014-09-08
JP2014237705A (en)	2014-12-18
WO2013084971A1 (en)	2013-06-13
KR101809695B1 (en)	2017-12-15
MY172363A (en)	2019-11-21
AU2012349340B2 (en)	2015-11-05
JP2015108010A (en)	2015-06-11
JPWO2013084971A1 (en)	2015-04-27
EP2789340A4 (en)	2015-07-22
AU2012349340A1 (en)	2014-07-24
EP2789340A1 (en)	2014-10-15
US10245291B2 (en)	2019-04-02
US20170119828A1 (en)	2017-05-04
CA2861533A1 (en)	2013-06-13
US20140322172A1 (en)	2014-10-30
JP5690435B2 (en)	2015-03-25
KR20150000867A (en)	2015-01-05
SG10201609078TA (en)	2016-12-29
KR20170104629A (en)	2017-09-15
JP5690416B2 (en)	2015-03-25
CA2861533C (en)	2020-07-14
CN104010648A (en)	2014-08-27
JP6165185B2 (en)	2017-07-19

Publication	Publication Date	Title
SG10201609078TA (en)	2016-12-29	Lipid Metabolism And/Or Sugar Metabolism Improver Containing Lactic Acid Bacterium Or Treatment Product Thereof
EP2705140B8 (en)	2018-04-25	Novel lactic acid bacteria and compositions containing them
IL228875A0 (en)	2013-12-31	Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
HK1207110A1 (en)	2016-01-22	Use of lactic acid bacteria for preparing fermented food products with increased natural sweetness
EP2675899A4 (en)	2014-09-10	Biosynthesis of human milk oligosaccharides in engineered bacteria
GB201117313D0 (en)	2011-11-16	Bacterium for use in medicine
LT2632277T (en)	2018-06-11	Milk product and preparation method
HRP20190499T1 (en)	2019-05-03	Product including lactic acid bacteria and a desiccant
EP2757147A4 (en)	2015-05-27	Sugar solution production apparatus and sugar solution production system
ZA201408583B (en)	2016-01-27	Food hygiene method and food product
GB201120966D0 (en)	2012-01-18	Confectionery products and their manufacture
EP2697389A4 (en)	2014-09-10	Osteoblast-expressed lipocalin 2 regulates glucose metabolism
HK1201030A1 (en)	2015-08-21	Synbiotic food composition containing tagatose and probiotic lactic acid bacteria
EP2528612A4 (en)	2013-07-17	Methods of treating glucose metabolism disorders
EP2528614A4 (en)	2013-09-04	Methods of treating glucose metabolism disorders
EP2523730A4 (en)	2013-10-23	Methods of treating glucose metabolism disorders
GB2525526B (en)	2016-05-11	Food hygiene method and food product
AU2011901521A0 (en)	2011-05-12	Treatment of abnormalities of glucose metabolism 2
TWM386837U (en)	2010-08-21	Improved structure of refrigerating and displaying cabinet for commercial products
GB201302086D0 (en)	2013-03-20	Fermentation methods and their products
GB201114177D0 (en)	2011-10-05	Food product and process